The spring meeting of the OOG was held in Copenhagen on the 15-17th April 2011.

Click here for the photoalbum.

Click here for the minutes of the business meeting.

Programme
Friday, 15 April 2011
Arrival in Copenhagen during the afternoon

17:00 � 18:00      Tour by boat in the Copenhagen habour and canals (Meeting point: Stormbroen).

18:30                 Peder Oxe's Restaurant and Vink�lder Wine Bar Gr�br�dretorv 11,
1154 K�benhavn (Cost: �50 per person, excluding beverages)


Saturday, 16 April 2011Meeting point both days: University of Copenhagen, 10 Noerregade, Copenhagen

Saturday, 16 April 2011

8:45 - 9:00     Welcome by the Local Organizers and the OOG President


Session IModerators:      Laurence Desjardins and Jan Prause


9:00 � 9:12     Munier FL, Balmer A, Beck-Popovic M, Binaghi S
Superselective ophthalmic chemotherapy for advanced retinoblastoma


9:12 � 9:18    Kivel� T, Seitsonen S, Pihkala U, Tenhunen M, Lindahl P, Koskinen L
Cure of an ectopic intracranial retinoblastoma with chemotherapy and stereotactic radiotherapy


9:18 � 9:24    Kiilgaard JF, Bagger M, Prause JU, Fiil Urbak S, Heegaard S
Retinoblastoma in a 16-year-old girl


9:24 � 9:36     Vishnevskia-Dai V, Rosner M, Elhalel A, Moroz I, Sigal R, Moisseiev J
Vasoproliferative lesions of the retina and the optic disc


9:36 � 9:48    Frenkel S, Zloto O, Pe�er J
Gender differences in clinical presentation and prognosis of uveal melanoma


9:48 � 10:00    Romanowska-Dixon B, Pogrzebielski A, Jakubowska B
High-frequency ultrasound imaging and optical coherence tomography for anterior segment tumors diagnosis


10:00 � 10:12    Habal S, Krema H, Gonzalez E, Simpson ER, Pavlin JC
Optical coherence tomography (OCT) verification of minimal subretinal fluid detected ultrasonographically in choroidal melanocytic lesions


10:12 � 10:24    van den Bosch T, Vaarwater J, Mensink H, Kili� E, Paridaens D, de Klein A
There is no significant role for PARK2 deletions or mutations in uveal melanoma patients


10:30 �11:00     Coffee Break (and poster viewing)

11:00 � 11:45 Guest Lecture: Per Guldberg, Professor and Head of the Department of Cancer Genomics, Institute of Cancer Biology, Danish Cancer Society 
The genome and epigenome of melanoma. What does it tell us about biology?


Session IIModerators:     Edoardo Midena and Ann Schalenbourg


11:45 �  11:57     Jager MJ, Bronkhorst IHG, Jordanova K, Kroes M, Luyten GPM,
Heterogeneous distribution of chromosome 3 and prognosis in uveal melanoma


11:57 � 12:03    Coupland SE, Dodson A, Damato BE
A rare case report of a uveal collision tumor: A collision of two worlds


12:03 � 12:15    Moulin AP, Michielin O, Schalenbourg A, Zografos L, Leyvraz S, Rimoldi D
Synthetic lethality in uveal melanoma: a pilot study with PARP inhibitors


12:15 � 12:27    Cohen VML, Tsimpida M, Arora A, Hungerford JL
Plaque radiotherapy treatment with Ruthenium-106 for iris malignant melanoma


12:30 � 13:30    Lunch

Session IIIModerators:     Bertil Damato and Leonidas Zografos


13:30 � 13:42    Razzaq L, Jager MJ, Zwaan J, Marinkovic M, Luyten GPM, de Keizer RJW
Ruthenium-106 plaque brachytherapy for iris melanoma and its effect on corneal endothelium


13:42 � 13:54    Sandinha MT, Kenaway N, Coupland S, Damato BE
Recurrence of iris melanoma after proton beam therapy


13:54 � 14:00    Pogrzebielski A, Romanowska-Dixon B, Markiewicz A, Swako? J, Sulikowski J, Olko P
New proton beam radiotherapy facility in Europe � experience with first patient treated in Krakow


14:00 � 14:12    Foerster MH, Moser L
Proton beam radiation in choroidal hemangioma


14:12 � 14:24    Caujolle JP, Maschi C, Freton A, Pages G, Gastaud P
Treatment of post-protontherapy neovascular glaucoma in uveal melanomas with Ranibizumab injection: Preliminary results


14:24 � 14:36    Desjardins L, Lumbroso-LeRouic L, Levy C, Cassoux N, Dendale R, Plancher C, Asselain B
Retrospective review of 15 years of treatment of uveal melanoma by proton beam


14:36 � 14:48    Zografos L, Schalenbourg A
Hemodynamic modifications of the choro�d and retina following proton beam irradiation of uveal melanomas


14:48 � 14:54    Grange JD, Jean-Louis B, Schalenburg A, Zografos L, Shishe boran Devouassoux M, Kodjikian L, Beccat S
Diffuse uveal melanoma: A difficult diagnosis (report of one case with review of literature)


15:00 � 15:30   Coffee Break (and poster viewing)

Session IV (including Business Meeting)Moderators:     Jacob Pe'er and Michael Foerster


15:30 � 15:42    Saakyan SV, Shirina TV, Amiryan AG
Uveal melanoma long-term survival estimation after brachytherapy and enucleation


15:42 � 15:54    Kivel� T, Salkola S, Eskelin S, Heikkonen J
Tumour recurrences after managing small posterior choroidal melanomas with 10 mm ruthenium plaques


15:54 � 16:06    Parrozzani R, Pilotto E, Dario A, Midena E
Prompt versus delayed intravitreal Triamcinolone injection for serous retinal detachment secondary to posterior uveal melanoma


16:06 � 16:18
Suesskind D, Schatz A Schnichels S, Coupland SE, Lake SL, Wissinger B, Bartz-Schmidt KU, Henke-Fahle S
GDF-15: a novel serum marker for metastases in uveal melanoma patients


16:18 � 16:30    Frenkel S, Barak V, Zloto O, Pe�er J
Novel biomarkers for detecting uveal melanoma metastases


16:30 � 17:30 Business meeting:1.    Approval of Minutes of previous Business Meeting (Crete, October 2010)
2.    Financial report 
3.    OOG Website update
4.    Nominations for membership to OOG
5.    Young Investigator Awards
6.    Update on current collaborative studies/new proposals
7.    Announcement of upcoming elections
8.    Details of next OOG Meetings
9.    Any Other Business (AOB)
10.    Closure of Business Meeting


18:45                  Meeting pt: main entrance of Tivoli, 3 Vesterbrogade, Copenhagen
19:00                 Dinner at Restaurant Paafuglen, Tivoli